Selecting a Favorable KIR Donor in Unrelated HCT for AML
NCT01288222
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
506
Enrollment
OTHER
Sponsor class
Conditions
Acute Myelogenous Leukemia
Interventions
OTHER:
KIR genotype
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
[object Object]